Essex Investment Management’s Syneron Medical Ltd ELOS Stock Holding History

Essex Investment Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-182,033	Closed	-$1.92M	–	388
2017 Q1	$1.92M	Buy	182,033 +39,401	+28%	+$381K	0.3%	95
2016 Q4	$1.2M	Buy	+142,632	New	+$1.12M	0.2%	133
2014 Q2	–	Sell	-108,580	Closed	-$1.35M	–	394
2014 Q1	$1.35M	Buy	108,580 +11,084	+11%	+$131K	0.2%	161
2013 Q4	$1.2M	Buy	+97,496	New	+$1.01M	0.17%	168
2013 Q3	–	Sell	-77,520	Closed	-$674K	–	402
2013 Q2	$674K	Buy	+77,520	New	+$693K	0.12%	195

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Essex Investment Management's ELOS Position: Q2 2017 in Review

Essex Investment Management sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 182,033 shares — an estimated $1.92M sold.

Essex Investment Management first reported a position in ELOS in Q2 2013 and held it in 5 quarters. The position peaked at $1.92M in Q1 2017. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

Essex Investment Management reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
Essex Investment Management sold 182,033 Syneron Medical Ltd shares in Q2 2017, an estimated $1.92M.
Essex Investment Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 5 quarters.
Essex Investment Management's Syneron Medical Ltd position peaked at $1.92M in Q1 2017.
79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Essex Investment Management's 13F filing for Q2 2017, filed 28 Jul 2017.